An Immunohistochemical study of HER-2 expression in feline mammary tumours.
The aim of the present study was to evaluate HER-2 expression in feline mammary tumours. Five different immunohistochemical protocols were tested with 73 feline mammary carcinomas (MCs), 10 mammary adenomas and 73 hyperplastic or dysplastic mammary lesions. The histological features of these lesions, clinical follow-up and expression of Ki-67 and p53 were also examined. With an optimized immunohistochemical protocol, HER-2 overexpression was detected in only four of the 73 (5.5%) MCs and did not correlate with histological classification or with the 1 year post-surgical clinical outcome. No correlation was found between the expression of Ki-67 or p53 and HER-2. Five of the 73 (6.8%) hyperplastic or dysplastic lesions and one of the 10 (10%) mammary adenomas were HER-2 positive. These results suggest that HER-2 may not play as significant role in mammary carcinogenesis and prognosis in cats as it does in human patients.
Rasotto
R
R
Department of Public Health, Comparative Pathology and Veterinary Hygiene, University of Padua, Italy. roberta.rasotto@unipd.it
Caliari
D
D
Castagnaro
M
M
Zanetti
R
R
Zappulli
V
V
D000236:Adenoma / Q000378:metabolism* / Q000473:pathology / Q000662:veterinary; D000818:Animals; D002371:Cat Diseases / Q000378:metabolism*; D002415:Cats; D005260:Female; D005348:Fibrocystic Breast Disease / Q000378:metabolism* / Q000473:pathology / Q000662:veterinary; D007150:Immunohistochemistry / Q000662:veterinary; D015674:Mammary Neoplasms, Animal / Q000378:metabolism* / Q000473:pathology; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*
D018719:Erb-b2 Receptor Tyrosine Kinases